BAKER DOUGLAS P

About BAKER DOUGLAS P

Douglas P. Baker is a U.S. business executive with a long-standing background in corporate finance and public-company operations, closely associated with OptimizeRx Corp. He joined OptimizeRx in May 2014 as Chief Financial Officer and also served as Principal Accounting Officer and in other senior leadership capacities at the company. His professional profile centers on financial reporting, SEC compliance, strategic planning, investor relations, and the disciplined management of public-company obligations. Before joining OptimizeRx, Baker spent roughly 18 years as Chief Financial Officer of Applied Nanotech Holdings, Inc., a publicly traded company focused on nanotechnology research and licensing. That role gave him extensive experience with capital markets, fundraising structures, mergers and acquisitions, restructurings, budgeting, forecasting, and compliance. His broader background also includes earlier work in public accounting at Plante Moran, financial leadership in a privately held printing company, and divisional finance roles at MascoTech, a Fortune 500 automotive supplier. Taken together, these roles show a career built around finance leadership in complex operating environments. Baker’s experience extends beyond day-to-day finance into governance. He served on the board of Applied Nanotech Holdings and was also a longtime board member of Total Health Care, Inc., a Detroit-based health maintenance organization. He later became chairman of that board before the organization was acquired by Priority Health in January 2020. This governance experience adds depth to his executive background, particularly in regulated and stakeholder-intensive sectors. Academically, Baker holds a B.B.A. from the University of Michigan and an MBA from the University of Michigan-Flint. His career reflects a practical, hands-on finance leadership style with strengths in SEC reporting, strategic business planning, fundraising, turnaround situations, and board-level oversight. For SEO purposes, he is best described as an experienced chief financial officer and corporate governance professional with notable public-company leadership experience.